These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38277943)

  • 1. Editorial overview: "Purinergic immune cell regulation reveals novel pharmacological targets".
    Junger W; Ledderose C
    Curr Opin Pharmacol; 2024 Apr; 75():102435. PubMed ID: 38277943
    [No Abstract]   [Full Text] [Related]  

  • 2. Purinergic Signalling in Immune System Regulation in Health and Disease.
    Sévigny J; Martín-Satué M; Pintor J
    Mediators Inflamm; 2015; 2015():106863. PubMed ID: 26300587
    [No Abstract]   [Full Text] [Related]  

  • 3. Purinergic signalling in neuron-glia interactions.
    Fields RD; Burnstock G
    Nat Rev Neurosci; 2006 Jun; 7(6):423-36. PubMed ID: 16715052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune cell regulation by autocrine purinergic signalling.
    Junger WG
    Nat Rev Immunol; 2011 Mar; 11(3):201-12. PubMed ID: 21331080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting purinergic signaling for perioperative organ protection.
    Eltzschig HK
    Anesthesiology; 2013 May; 118(5):1001-4. PubMed ID: 23360900
    [No Abstract]   [Full Text] [Related]  

  • 6. ATP- and adenosine-mediated signaling in the central nervous system: purinergic receptor complex: generating adenine nucleotide-sensitive adenosine receptors.
    Yoshioka K; Nakata H
    J Pharmacol Sci; 2004 Feb; 94(2):88-94. PubMed ID: 14978342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic signaling as a target for emerging neurotherapeutics.
    Engel T; Sperlagh B
    Brain Res Bull; 2019 Sep; 151():1-2. PubMed ID: 31163189
    [No Abstract]   [Full Text] [Related]  

  • 8. Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance.
    Verkhratsky A; Burnstock G
    Bioessays; 2014 Jul; 36(7):697-705. PubMed ID: 24782352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic targets in the rapidly expanding field of purinergic signalling.
    Burnstock G
    Clin Med (Lond); 2002; 2(1):45-53. PubMed ID: 11871639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Purinergic receptor activation and phospholipid-Ca signal transduction systems].
    Kondo Y
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):240-50. PubMed ID: 1850854
    [No Abstract]   [Full Text] [Related]  

  • 11. Purinergic signalling: an experimental perspective.
    Housley GD; Thorne PR
    J Auton Nerv Syst; 2000 Jul; 81(1-3):139-45. PubMed ID: 10869712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic signaling in the retina: From development to disease.
    Ventura ALM; Dos Santos-Rodrigues A; Mitchell CH; Faillace MP
    Brain Res Bull; 2019 Sep; 151():92-108. PubMed ID: 30458250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unresolved issues and controversies in purinergic signalling.
    Burnstock G
    J Physiol; 2008 Jul; 586(14):3307-12. PubMed ID: 18499722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic regulation of hypothalamopituitary functions.
    Stojilkovic SS
    Trends Endocrinol Metab; 2009 Nov; 20(9):460-8. PubMed ID: 19800813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic signalling: past, present and future.
    Burnstock G
    Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview. Purinergic mechanisms.
    Burnstock G
    Ann N Y Acad Sci; 1990; 603():1-17; discussion 18. PubMed ID: 1981306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.
    Hasan D; Shono A; van Kalken CK; van der Spek PJ; Krenning EP; Kotani T
    Purinergic Signal; 2022 Mar; 18(1):13-59. PubMed ID: 34757513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of purinergic receptor-evoked increases in intracellular Ca2+ transients in isolated human and rodent insulin-secreting cells. Purinergic receptor signalling and [Ca2+]i in human beta-cells.
    Squires PE; James RF; London NJ; Dunne MJ
    Adv Exp Med Biol; 1997; 426():173-9. PubMed ID: 9544271
    [No Abstract]   [Full Text] [Related]  

  • 19. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling.
    Seiffert K; Ding W; Wagner JA; Granstein RD
    J Invest Dermatol; 2006 May; 126(5):1017-27. PubMed ID: 16410784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.